Japanese PAL - Navigating the Japanese Pharmaceutical Affairs Law

Instructor: Phil Smart
Product ID: 701276
  • Duration: 90 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Apr-2009

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

This JPAL training will emphasize on Japanese Pharmaceutical Affairs law with respect to - Classification, device approvals, clinical data, MAH (Marketing Authorization Holder),foreign manufacturer accreditation,QMS,post-market complaints & vigilance

For medical device and pharmaceutical manufacturers, the 2005 revisions to the Japanese Pharmaceutical Affairs Law (PAL) are in force. This presentation will take you through the PAL, its key regulatory players, essential concepts, applicable ordinances, conformity assessment paths and associated compliance requirements. Particular attention will be placed on implications for the foreign medical device manufacturer, from pre-market submissions to post-market surveillance.

Areas Covered in the seminar:
  • Overview of the PAL.
  • Roles of MHLW and PMDA.
  • Applicable ordinances for GQP, GMP, GVP, etc.
  • Role of the MAH in Japan and ties to the foreign manufacturer.
  • JPAL Product classification.
  • Shonin approval process.
  • Ninsho 3rd party certification process.
  • Acceptance of foreign clinical data.
  • Clinical data and GCP.
  • Foreign Manufacturer Accreditation.
  • QMS and Ministerial Ordinance 169.
  • Post-market complaint handling / vigilance.

Who Will Benefit:
  • This webinar will provide valuable assistance to quality, regulatory and manufacturing associates, whose companies sell or plan to sell their medical or pharmaceutical products in Japan.

Instructor Profile:
Phil Smart, is a founding member and Regulatory Consultant of RA/QA International LLC. He serves as Consultant, Auditor and Instructor, covering medical device regulations and standards within the US, Europe, Canada and Japan. He has spent over seven years in Tokyo and is a former head of operations and medical device assessment activities for TUV in Japan.

He has been a European Notified Body Lead Assessor and Monitoring Auditor for over 15 years with auditing experience in a wide range of active and non-active medical device technologies.

Follow us :
Upcoming In-person Seminars by EX-FDA OFFICIALS
FDA's Regulation of Regenerative Medicine including Stem Cell Treatments

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed